182 related articles for article (PubMed ID: 11699800)
1. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.
James RS; Sharp WS; Bastain TM; Lee PP; Walter JM; Czarnolewski M; Castellanos FX
J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1268-76. PubMed ID: 11699800
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
3. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.
McCracken JT; Biederman J; Greenhill LL; Swanson JM; McGough JJ; Spencer TJ; Posner K; Wigal S; Pataki C; Zhang Y; Tulloch S
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):673-83. PubMed ID: 12921475
[TBL] [Abstract][Full Text] [Related]
4. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
[TBL] [Abstract][Full Text] [Related]
5. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
Faraone SV; Wigal SB; Hodgkins P
J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
7. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting.
Swanson J; Wigal S; Greenhill L; Browne R; Waslick B; Lerner M; Williams L; Flynn D; Agler D; Crowley KL; Fineberg E; Regino R; Baren M; Cantwell D
Psychopharmacol Bull; 1998; 34(1):55-60. PubMed ID: 9564199
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD.
Greenhill LL; Swanson JM; Steinhoff K; Fried J; Posner K; Lerner M; Wigal S; Clausen SB; Zhang Y; Tulloch S
J Am Acad Child Adolesc Psychiatry; 2003 Oct; 42(10):1234-41. PubMed ID: 14560174
[TBL] [Abstract][Full Text] [Related]
9. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
10. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.
McGough JJ; Biederman J; Wigal SB; Lopez FA; McCracken JT; Spencer T; Zhang Y; Tulloch SJ
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):530-8. PubMed ID: 15908835
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.
McGough JJ; Biederman J; Greenhill LL; McCracken JT; Spencer TJ; Posner K; Wigal S; Gornbein J; Tulloch S; Swanson JM
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):684-91. PubMed ID: 12921476
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
13. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.
Brams M; Moon E; Pucci M; López FA
Curr Med Res Opin; 2010 Aug; 26(8):1809-25. PubMed ID: 20491612
[TBL] [Abstract][Full Text] [Related]
14. Improvements in executive function correlate with enhanced performance and functioning and health-related quality of life: evidence from 2 large, double-blind, randomized, placebo-controlled trials in ADHD.
Brown TE; Landgraf JM
Postgrad Med; 2010 Sep; 122(5):42-51. PubMed ID: 20861587
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E
J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.
Pliszka SR; Browne RG; Olvera RL; Wynne SK
J Am Acad Child Adolesc Psychiatry; 2000 May; 39(5):619-26. PubMed ID: 10802980
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of lisdexamfetamine and mixed amphetamine salts immediate release in adult ADHD: results of a crossover design clinical trial.
Adler LA; Alperin S; Leon T; Faraone S
Postgrad Med; 2014 Sep; 126(5):17-24. PubMed ID: 25295646
[TBL] [Abstract][Full Text] [Related]
18. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
19. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.
Pelham WE; Gnagy EM; Chronis AM; Burrows-MacLean L; Fabiano GA; Onyango AN; Meichenbaum DL; Williams A; Aronoff HR; Steiner RL
Pediatrics; 1999 Dec; 104(6):1300-11. PubMed ID: 10585981
[TBL] [Abstract][Full Text] [Related]
20. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
